Zercepac 150 mg powder for concentrate for solution for infusion.

DRUG2 trials

Sponsors

Institut fuer Klinische Krebsforschung IKF GmbH, Unicancer

Conditions

Advanced Biliary Cancer (ABC)cholangiocarcinoma or gallbladder carcinoma

Phase 2

TRAP-BTC Efficacy and safety of GemCis plus Trastuzumab plus Pembrolizumab in previously untreated HER2-positive biliary tract cancer

RecruitingCTIS2023-505722-33-00

Institut fuer Klinische Krebsforschung IKF GmbHcholangiocarcinoma or gallbladder carcinoma

Start: 2024-04-15Target: 24Updated: 2026-01-22

Phase 3

SAFIR ABC10 : Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, platform phase 3 trial

RecruitingCTIS2023-508100-38-00

UnicancerAdvanced Biliary Cancer (ABC)

Start: 2024-06-24Target: 450Updated: 2025-05-14